NCT06931600

Brief Summary

Our primary aim with this trial is to measure participant blinding following two simulated/sham or genuine/real high velocity, low amplitude (HVLA) manual chiropractic adjustments to assess if participants are able to identify their un-disclosed treatment group. Our secondary aims with this trial are to utilize electrocardiography (ECG), impedance cardiography (ICG), and gait analysis before either treatment session and after both treatment sessions to assess if there are any changes with the participants' measurements before and after a sham or genuine HVLA chiropractic treatment.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

May 5, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

March 28, 2025

Last Update Submit

March 25, 2026

Conditions

Keywords

randomizedsham-controlledchiropracticblindinggait analysisimpedance cardiographymovement parameterselectrocardiographyautonomic nervous systemHeart Rate Variability

Outcome Measures

Primary Outcomes (3)

  • Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Immediately post-session 1 (day 1)

  • Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Immediately pre-session 2 (day 2)

  • Participant blinding

    The blinding index is scaled to an internal of -1 to +1, +1 being complete lack of blinding, 0 being consistent with perfect blinding, -1 indicating opposite guessing which may be related to unblinding.

    Immediately post-session 2 (day 2)

Secondary Outcomes (12)

  • High-frequency Heart Rate Variability (HF-HRV)

    baseline

  • High-frequency Heart Rate Variability (HF-HRV)

    post-session 2 (day 2)

  • Pre-ejection period (PEP)

    baseline

  • Pre-ejection period (PEP)

    post-session 2 (day 2)

  • The speed of the participants will be assessed at baseline as part of the gait analysis.

    baseline

  • +7 more secondary outcomes

Study Arms (2)

Simulated/sham

SHAM COMPARATOR

30 individuals receiving simulated/sham chiropractic interventions

Procedure: Sham adjustment

Genuine/real

EXPERIMENTAL

30 individuals receiving genuine/real chiropractic interventions

Procedure: Chiropractic adjustment

Interventions

Two manual high velocity, low amplitude (HVLA) simulated/sham chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions

Simulated/sham

Two manual high velocity, low amplitude (HVLA) genuine/real chiropractic interventions in the cervical, thoracic, and/or lumbopelvic regions

Genuine/real

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
* No history of stroke or transient ischemic attack or current symptoms including: Dizziness or vertigo; Tinnitus (ringing in the ears); Visual, sensory, or motor disturbances * No new pattern headache complaint * No recent whiplash injury (within 3 mo) * No spinal fractures/dislocations * No disc problems with radiating symptoms to the arms or legs * No severe degenerative joint disease in the spine * No connective tissue disorders * No primary fibromyalgia * No metabolic or metaplastic bone disease * No diagnosed condition that causes fainting during postural changes, such as POTS or orthostatic hypotension * No history of cervical, thoracic, or lumbar spine surgery * No uncontrolled high blood pressure or vascular disease * No current use of anticoagulant therapy * No current use of short-acting benzodiazepines, including midazolam \& triazolam * No change in medications in the past 6 weeks or intentions to change medications during the study * Inability to walk unassisted on a treadmill * No pacemakers or known heart conditions that influence the electrical or mechanical function of the heart, such as severe heart valve disease * Not a DC or a DC student enrolled 4th quarter or above * No present, self-reported pregnancy * No chiropractic care in the 2 weeks prior to participation * Did not participate in the feasibility study for this pilot (Perceptions and experiences following a single session of simulated or genuine high velocity, low amplitude (HVLA) manual chiropractic adjustments)

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Dr. Sid E. Williams Center for Chiropractic Research

Marietta, Georgia, 30067, United States

Location

Related Publications (1)

  • Sliwka M, Perez T, Qazi A, Sullivan S. Spinal Manipulative Therapy on a Healthy Population: Protocol for a Randomized Blinding Feasibility Trial. JMIR Res Protoc. 2026 Mar 27;15:e85956. doi: 10.2196/85956.

MeSH Terms

Conditions

Joint Dislocations

Interventions

Manipulation, Chiropractic

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeutics

Study Officials

  • Tyson Perez, DC, PhD

    Life University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Lab coordinator
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: randomized, sham-controlled, pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 17, 2025

Study Start

May 5, 2025

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations